{"id":"W2117505171","doi":"10.1111/dom.12187","title":"Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"Astellas Pharma; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Insulin; Adverse effect; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Urology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001570651,0.0002368906,0.0009838655,0.0002229826,0.0001976451,0.0004711872,0.0001635837,0.000403064,0.0008662566],"category_scores_gemma":[0.001651524,0.0001652374,0.0004914738,0.0003017546,0.0001799708,0.0003572192,0.0001931526,0.0006158937,0.0001255741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000276599,"about_ca_system_score_gemma":0.0002920228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002863407,"about_ca_topic_score_gemma":0.0005538028,"domain_scores_codex":[0.999584,0.0001857885,0.00005234921,0.00006185721,0.00007600358,0.00004001663],"domain_scores_gemma":[0.9993216,0.000213663,0.000263311,0.00003370949,0.00004044529,0.000127237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5208618,0.006905672,0.1908945,0.0009434929,0.001623798,0.0003444176,0.0001915409,0.0009491805,0.009044899,0.00008383045,0.001595366,0.2665616],"study_design_scores_gemma":[0.1346944,0.2525155,0.5962463,0.0002521048,0.002501631,0.001134285,0.0001824492,0.004335777,0.003565894,0.0002225228,0.004290944,0.00005830721],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931746,0.005751899,0.0002046382,0.000113847,0.00004484998,0.0001102716,0.0000980464,0.00001074227,0.0004909423],"genre_scores_gemma":[0.9973143,0.001626824,0.0003418145,0.0002009278,0.00009732122,0.0001108712,0.000141567,0.000001653386,0.0001646801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001570651,"threshold_uncertainty_score":0.008306503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004339992995139996,"score_gpt":0.1913791158533762,"score_spread":0.1870391228582363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}